Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   MK-6204 (SKB535) for Injection · Advanced Solid Tumors

   Enrollment increased: 90 → 142 participants

   Also in this update: Trial sites expanded: 7 → 10 locations

   Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.·Phase 1· NCT06726369· Registry history of NCT06726369 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.